tanimilast: Clinical Trials

4 trials of tanimilast, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4

Follow tanimilast: new trials by email Literature Review of tanimilast trials Research Report on tanimilast

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of CHF6001 in Subjects With Mild, Moderate and Severe Liver Impairment in Comparison With Matched Healthy Control Subjects
CHF6001 - Chronic Obstructive Pulmonary Disease
Phase 1CompletedChiesi Farmaceutici S.p.A.442022-05-052024-04-15
Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects
CHF6001 - Chronic Obstructive Pulmonary Disease (COPD), COPD
Phase 1CompletedChiesi Farmaceutici S.p.A.82021-03-102024-03-18
Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001
CHF5259 and CHF6001, CHF5259 + placebo, CHF6001 + placebo - Copd
Phase 1CompletedChiesi Farmaceutici S.p.A.362016-01-012016-12-29
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001
Single Ascending Dose (SAD), Multiple Ascending Dose (MAD) - Chronic Obstructive Pulmonary Disease
Phase 1CompletedChiesi Farmaceutici S.p.A.482014-11-012020-07-31

Conditions studied

Pulmonary Disease, Chronic Obstructive (4)

Sponsors

Chiesi Farmaceutici S.p.A. (4)

Countries

United Kingdom (3)  ·  Bulgaria (1)

Top investigators

Ronnie Beboso, MD (1)  ·  Stuart Mair, MD (1)

Results publications

PMID 30425469, PMID 40391696